Arany I, Safirstein RL: Cisplatin Nephrotoxocity. Seminars in Nephrology. 2003, 23: 460-464. 10.1016/S0270-9295(03)00089-5.
Article
CAS
PubMed
Google Scholar
Fillastre JP, Raguenez-Viotte G: Cisplatin nephrotoxicity. Toxicol Lett. 1989, 46: 163-175. 10.1016/0378-4274(89)90125-2.
Article
CAS
PubMed
Google Scholar
Cornelson TL, Reed E: Nephrotoxicity and hydration management for Cisplatin, Carboplatin und Ormaplatin. Gynecologic Oncology. 1993, 50: 147-158. 10.1006/gyno.1993.1184.
Article
Google Scholar
Goren MP: Cisplatin Nephrotoxicity affects Magnesium and Calcium Metabolism. Medical and Pediatric Oncology. 2003, 41: 186-189. 10.1002/mpo.10335.
Article
PubMed
Google Scholar
Weiss-Guillet EM, Takala J, Jakob SM: Diagnosis and management of electrolyte emergencies. Best Practise, Research Clinical Endocrinology and Metabolism. 2003, 17: 623-651. 10.1016/S1521-690X(03)00056-3.
Article
CAS
Google Scholar
Pattou F, Combemale F, Fabre S, Carnaille B, Decloux M, Wemenau JL, Racadot A, Proye C: Hypocalcaemia following thyroid surgery: incidence and prediction of the outcome. World Journal of Surgery. 1998, 22: 718-724. 10.1007/s002689900459.
Article
CAS
PubMed
Google Scholar
Prough DS: Physiologic acid-base and electrolyte changes in acute and chronic renal failure patients. Anesthesiol Clin North America. 2000, 18: 809-833. 10.1016/S0889-8537(05)70196-6.
Article
CAS
PubMed
Google Scholar
Hadjis T, Grieff M, Lockhat D, Kaye M: Calcium metabolism in acute renal failure due to rhabdomyolysis. Clin Nephrol. 1993, 39: 22-27.
CAS
PubMed
Google Scholar
Pitchumoni CS, Agarwal N, Jain NK: Systemic complications of acute pancreatitis. Am J Gastroenterol. 1988, 83: 597-606.
CAS
PubMed
Google Scholar
Bazarbashi S, Rahal M, Raja MA, Weshi AE, Pai C, Ezzat A, Hanash K: A Pilot Trial of Combination Cisplatin, 5-Fluorouracil and Interferon-alpha in the Treatment of Advanced Oesophageal Carcinoma. Chemotherapy. 2002, 48: 211-216. 10.1159/000063870.
Article
CAS
PubMed
Google Scholar
Picozzi VJ, Traverso LW: The Virginia Mason approach to localized pancreatic cancer. Surg Oncol Clin N Am. 2004, 663-674. 10.1016/j.soc.2004.06.002.
Google Scholar
Bazarbashi S, Pai C, Raja MA, Rahal M, Ezzat A, Hanash K: Phase II Trial of cisplatin, 5-fluorouracil, and interferon-alpha.2B as first line treatment of advanced urothelial cancer. Urologic Oncology. 2003, 21: 185-189.
Article
CAS
PubMed
Google Scholar
Vokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Kozloff M, Hamasaki V, Weichselbaum RR, Panje RR, Wenig B: Cisplatin, Fluorouracil, and Leucovorin augmented by Interferon Alfa-2b in Head and Neck Cancer: A Clinical and Pharmacologic Analysis. Journal of Clinical Oncology. 1993, 11: 360-368.
CAS
PubMed
Google Scholar
Knaebel HP, Maerten A, Schmidt J, Hoffmann K, Seiler C, Lindel K, Schmitz-Winnenthal HF, Fritz S, Hermann T, Goldschmidt H, Mansmann U, Debus J, Diehl V, Buchler MW: Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic carcinoma – CapRI: study protocoll (ISRCTN62866759). BMC Cancer. 2005, 5-
Google Scholar
Picozzi VJ, Kozarek RA, Traverso LW: Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. American Journal of Surgery. 2003, 185: 476-480. 10.1016/S0002-9610(03)00051-5.
Article
PubMed
Google Scholar
Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA: Magnesium transport in the renal distal convoluted tubule. Physiol Rev. 2001, 81: 51-84.
CAS
PubMed
Google Scholar
Yasumasu T, Ueda T, Uozumi J, Mihara Y, Kumazawa J: Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats. Pharmacol Toxicol. 1992, 70: 143-147.
Article
CAS
PubMed
Google Scholar
Hayes FA, Green AA, Senzer N, Pratt CB: Tetany: A Complication of Cis-Dichlorodiammineplatinum(II) Therapy. Cancer Treatment Reports. 1979, 63: 547-548.
CAS
PubMed
Google Scholar
Jones GJ, Itri LM: Safety and Tolerance of Recombinant Interferon Alfa-2b (Roferon-A) in Cancer Patients. Cancer. 1986, 57: 1709-1715.
Article
CAS
PubMed
Google Scholar
Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A: Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg. 2000, 135: 81-87. 10.1001/archsurg.135.1.81.
Article
CAS
PubMed
Google Scholar
Moutardier V, Turrini O, Huiart L, Viret F, Giovannini MH, Magnin V, Lelong B, Bories E, Guiramand J, Sannini A, Giovannini M, Houvenaeghel C, Blache JL, Moutradier JC, Delpero JR: A reappraisal of preoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single-institution experience. J Gastrointest Surg. 2004, 8: 502-510. 10.1016/j.gassur.2003.11.013.
Article
CAS
PubMed
Google Scholar